Clinical Study HPV Prevalence and Prognostic Value in a Prospective Cohort of 255 Patients with Locally Advanced HNSCC : A Single-Centre Experience

1 Department of Head and Neck Surgery, Centre Hospitalier de l’Université de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke Est, Montreal (Quebec), Canada H2L 4M1 2Department of Radiation Oncology, Hôpital Maisonneuve-Rosemont, 5415 Boulevard de l’Assomption, Montréal (Quebec), Canada H1T 2M4 3Department of Microbiology, Centre Hospitalier de l’Université de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke Est, Montreal (Quebec), Canada H2L 4M1 4Department of Radiation Oncology, Centre Hospitalier de l’Université de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke Est, Montreal (Quebec), Canada H2L 4M1 5Department of Haematology and Medical Oncology, Centre Hospitalier de l’Université de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke Est, Montreal (Quebec), Canada H2L 4M1 6 Laboratoire de Biologie Moléculaire et Hématologie Spéciale, Département d’Hématologie, Hématologue et Oncologue Médical, Centre Hospitalier de l’Université de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke Est, Montreal (Quebec), Canada H2L 4M1

[1]  K. Ang,et al.  Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  P. Gattuso,et al.  Ancillary Studies in Determining Human Papillomavirus Status of Squamous Cell Carcinoma of the Oropharynx: A Review , 2011, Pathology research international.

[3]  T. Ramqvist,et al.  Oropharyngeal Cancer Epidemic and Human Papillomavirus , 2010, Emerging infectious diseases.

[4]  F. Feng,et al.  Tobacco Use in Human Papillomavirus–Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence , 2010, Clinical Cancer Research.

[5]  A. Hui,et al.  Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  L. Terracciano,et al.  Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? , 2009, International journal of cancer.

[7]  P. Sparén,et al.  Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral‐induced carcinoma? , 2009, International journal of cancer.

[8]  Albert C. Koong,et al.  The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. , 2009, International journal of radiation oncology, biology, physics.

[9]  C. Tsien,et al.  EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  E. Speel,et al.  Marked differences in survival rate between smokers and nonsmokers with HPV 16‐associated tonsillar carcinomas , 2008, International journal of cancer.

[11]  W. Westra,et al.  Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. , 2008, Journal of the National Cancer Institute.

[12]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[13]  A. Chaturvedi,et al.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Taube,et al.  Inverse Relationship between Human Papillomavirus-16 Infection and Disruptive p53 Gene Mutations in Squamous Cell Carcinoma of the Head and Neck , 2008, Clinical Cancer Research.

[15]  C. R. Leemans,et al.  A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen , 2007, International journal of cancer.

[16]  M. Prystowsky,et al.  Gene expression profiles in HPV‐infected head and neck cancer , 2007, The Journal of pathology.

[17]  E. Taioli,et al.  Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysis , 2007, International journal of cancer.

[18]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[19]  H. Dienes,et al.  Combined analysis of HPV‐DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer , 2007, International journal of cancer.

[20]  M. Gillison.  Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  E. Munck‐Wikland,et al.  Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer , 2006, International journal of cancer.

[22]  M. Gillison,et al.  Clinical implications of human papillomavirus in head and neck cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  P. Schlag,et al.  Enhanced Detection and Typing of Human Papillomavirus (HPV) DNA in Anogenital Samples with PGMY Primers and the Linear Array HPV Genotyping Test , 2006, Journal of Clinical Microbiology.

[24]  D. Rimm,et al.  Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  A. Vaheri,et al.  Human papillomavirus type 16 in head and neck carcinogenesis , 2005, Reviews in medical virology.

[26]  N. Schlecht.  Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence. , 2005, Oncology reports.

[27]  S. Franceschi,et al.  Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.

[28]  D. Lindquist,et al.  Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients , 2004, International journal of cancer.

[29]  L. Turek,et al.  Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx , 2003, International journal of cancer.

[30]  F. Bosch,et al.  Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control , 2002, Oncogene.

[31]  J. Laissue,et al.  Human papillomavirus positive squamous cell carcinoma of the oropharynx , 2001, Cancer.

[32]  S. Schwartz,et al.  Human Papillomavirus Infection and Survival in Oral Squamous Cell Cancer: A Population-Based Study , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[33]  H. Höfler,et al.  Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. , 2001, The American journal of pathology.

[34]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[35]  F. Coutlée,et al.  Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction , 1997, Journal of medical virology.

[36]  C. Meijer,et al.  Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes , 1995, Journal of clinical microbiology.

[37]  J. Stockman.  Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer , 2012 .

[38]  M. Gapany.  Human Papillomavirus and Oropharynx Cancer: Biology, Detection and Clinical Implications , 2011 .

[39]  R. Fisher,et al.  Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial , 2010 .

[40]  J. Ensley,et al.  An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.